Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, February 01, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
TAdvanced Thermal Cycler with Silver Block
Saturday, January 31, 2015
Highest speed and reproducibility for ultimate PCR performance.

Luminex xMAP® Tracks 6 of the Most Dangerous Biotoxins
Saturday, January 24, 2015
Designed to fill the need for a high-performance multiplex screening assay.

Analytik Jena Launches CE IvD Kits for Dementia Diagnostics
Friday, January 23, 2015
Kits are easy and quick to use, and are well suited to automation on the relevant platforms in routine diagnostics.

QIAGEN Announces Regulatory Registration of a Lung Cancer Companion Diagnostic
Tuesday, January 13, 2015
therascreen EGFR RGQ Plasma PCR kit helps physicians to identify patients who could benefit from treatment with IRESSA when tumor tissue sample is not evaluable.

Illumina Expands World’s Most Comprehensive Next-Generation Sequencing Portfolio
Tuesday, January 13, 2015
New systems extend access to production-scale sequencing.

Real-time PCR Kit for Detection of the Zaire Ebola Virus
Thursday, January 08, 2015
CE labelled kit launched by Fast-track Diagnostics deliver fast and accurate diagnoses.

Activ8rlives to Develop its First Medical Smartwatch
Friday, December 19, 2014
BuddyWOTCH for continuous monitoring of oxygenation for UK’s Chronic Obstructive Pulmonary Disease patients.

Ebola Antigens and Antibodies for ELISA
Friday, December 19, 2014
AMSBIO products for the development of an ELISA detection assay for the Ebola virus.

Revolutionize Routine Medical Testing with Latest ‘Super-Control’ from Randox
Wednesday, December 17, 2014
'Super Control' will revolutionize quality control in laboratories.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 495
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn